pimagedine has been researched along with Experimental Mammary Neoplasms in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gauthier, N | 1 |
| Lohm, S | 1 |
| Touzery, C | 1 |
| Chantôme, A | 1 |
| Perette, B | 1 |
| Reveneau, S | 1 |
| Brunotte, F | 1 |
| Juillerat-Jeanneret, L | 1 |
| Jeannin, JF | 1 |
1 other study available for pimagedine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
Topics: Animals; Cell Adhesion; Cell Division; Cell Survival; Endothelial Cells; Enzyme Inhibitors; Female; | 2004 |